Ligand-based active targeting strategies for cancer theranostics

Area of Science:

• Nanomedicine
• Oncology
• Drug Delivery

Background:

• Nanomedicine shows promise in cancer theranostics for advanced stages.
• Current nanomedicine faces challenges with specificity and targeting efficiency.
• Ligand-decorated nanocarriers offer a solution to overcome these limitations.

Purpose of the Study:

• To explore nanocarrier-mediated ligand-based targeted drug delivery systems for cancer therapy.
• To highlight the advantages of ligand decoration in enhancing nanomedicine efficacy.
• To summarize the potential of these systems as cancer theranostics.

Main Methods:

• Review of preclinical and clinical studies on nanomedicine in cancer theranostics.
• Focus on ligand-decorated nanocarriers for targeted drug delivery.
• Analysis of enhanced retention and permeability of targeted nanocarriers.

Main Results:

• Ligand decoration significantly improves the specificity and targeting of nanocarriers.
• Enhanced retention and permeability lead to effective drug delivery at the tumor site.
• Nanocarrier-mediated targeted therapy demonstrates potential for in vivo cancer growth restriction without harming healthy cells.

Conclusions:

• Ligand-decorated nanocarriers represent a novel and promising approach for cancer theranostics.
• This targeted strategy enhances therapeutic outcomes and minimizes side effects.
• Further development holds significant potential for treating various cancers effectively.